Oramed Pharmaceuticals Inc. is an Israeli biotechnology company specializing in the development of oral drugs for patients with diabetes. The company focuses on the research and development of oral insulin and other peptide-based drugs that aim to replace the need for injectable administration. Oramed Pharmaceuticals seeks to provide more convenient and effective treatment options for patients with diabetes. Shares of Oramed Pharmaceuticals Inc. are traded on the stock exchange and may be an interesting investment opportunity for those following innovations in diabetes treatment.
Feed
There are no posts to show right now.
Używamy ciasteczek, aby ulepszyć Twoje doświadczenie na naszej stronie.
